Literature DB >> 26101561

Treatment of Cancer with NAMPT Inhibitors.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 26101561      PMCID： PMC4468406          DOI： 10.1021/acsmedchemlett.5b00187

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer.

Authors:  Mara Gallí; Frédéric Van Gool; Anthony Rongvaux; Fabienne Andris; Oberdan Leo
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

Review 2.  Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.

Authors:  Fabrizio Montecucco; Michele Cea; Inga Bauer; Debora Soncini; Irene Caffa; Denise Lasigliè; Aimable Nahimana; Antonio Uccelli; Santina Bruzzone; Alessio Nencioni
Journal:  Curr Drug Targets       Date:  2013-06-01       Impact factor: 3.465

Review 3.  Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.

Authors:  Ubaldina Galli; Cristina Travelli; Alberto Massarotti; Gohar Fakhfouri; Reza Rahimian; Gian Cesare Tron; Armando A Genazzani
Journal:  J Med Chem       Date:  2013-05-31       Impact factor: 7.446
  3 in total
  2 in total

Review 1.  Parahydrogen-Based Hyperpolarization for Biomedicine.

Authors:  Jan-Bernd Hövener; Andrey N Pravdivtsev; Bryce Kidd; C Russell Bowers; Stefan Glöggler; Kirill V Kovtunov; Markus Plaumann; Rachel Katz-Brull; Kai Buckenmaier; Alexej Jerschow; Francesca Reineri; Thomas Theis; Roman V Shchepin; Shawn Wagner; Pratip Bhattacharya; Niki M Zacharias; Eduard Y Chekmenev
Journal:  Angew Chem Int Ed Engl       Date:  2018-08-01       Impact factor: 15.336

2.  NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.

Authors:  Antonio Lucena-Cacace; Daniel Otero-Albiol; Manuel P Jiménez-García; Javier Peinado-Serrano; Amancio Carnero
Journal:  Oncotarget       Date:  2017-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.